VT News

Casey Barnes

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
  • Education Department narrows eligibility for Public Service Loan Forgiveness, allowing it to bar employers it deems to have an illegal purpose.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Morgan Wallen announces 'Still the Problem' 2026 stadium tour, highlighting his continued commercial success despite past controversies.
  • Education Department narrows eligibility for Public Service Loan Forgiveness, allowing it to bar employers it deems to have an illegal purpose.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Casey Barnes

Top Topics

Trending in U.S.

World

Sport